Interní Med. 2001; 3(12): 579-582

Genetika a kardiologie na prahu nového tisíciletí

MUDr. Jana Gandalovičová
II. interní klinika kardiologie a angiologie 1. LF UK a VFN, Praha

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gandalovičová J. Genetika a kardiologie na prahu nového tisíciletí. Interní Med. 2001;3(12):579-582.

Článek pojednává o dědičných kardiovaskulárních onemocněních, jejich genetickém přenosu a posledních objevech na tomto poli. Zmiňuje úlohu genetického testování a možnosti terapeutického ovlivnění dědičných nemocí.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Badorff, C., Berkely, A. et al. (2000): Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J Biol Chem 275: 11191-7. Go to original source... Go to PubMed...
    2. Bonne, G., Carrier, L. et al. (1998): Familial hypertrophic cardiomyopathy: from mutations to functional defects. CircRes. 83: 580-593. Go to original source... Go to PubMed...
    3. Cohn, J.N., Bristow, M.R. et al. (1997): Report of the National Heart, Lung and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation, 95: 766-770. Go to original source... Go to PubMed...
    4. Grunig, E., Tasman, J.A. et al. (1998): Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31: 186-194. Go to original source... Go to PubMed...
    5. Kamisago, M., Sharma, S.D., et al. (2000): Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 343: 1688-1696. Go to original source... Go to PubMed...
    6. Keane, M.G., Wiegers, S.E. (2000): Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. Circulation. 102: III35-9. Go to original source...
    7. Leiden, J.M. (2001): Chapter 55 - Principles of Cardiovascular Molecular Biology and Genetics. Braunwald: Heart Disease: A Textbook of Cardiovascular Medicine, 6 th ed. 1955-1974.
    8. Marian, A.J. (2000): Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet. 355: 58-60. Go to original source... Go to PubMed...
    9. Ortiz-Lopez, R., Li, H. et al. (1997): Evidence for dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation. 95: 2434-2440. Go to original source... Go to PubMed...
    10. Pereira, L., Levran, O. et al. (1994): Molecular approach to the stratification of cardiovascular risk in families with Marfan´s syndrome. N Engl J Med. 331: 148-153. Go to original source... Go to PubMed...
    11. Priori, S.G., Barhanin, J. et al. (1999): Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Part I and II. Circulation. 99: 518-528. Go to original source... Go to PubMed...
    12. Pyeritz, R.E. (2000): Ehlers-Danlos Syndrome. N Engl J Med 342: 730-732. Go to original source... Go to PubMed...
    13. Pyeritz, R.E. (2001): Genetics and Cardiovascular Disease. Braunwald: Heart Disease: A Textbook of Cardiovascular Medicine, 6 th ed.: W.B.Sauders Company.
    14. Seidman, C.E., Seidman, J.G. (1998): Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res Cardiol. 93: 13-16. Go to original source... Go to PubMed...
    15. Seidman, J.G., Seidman, C. (2001): The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 104: 557-567. Go to original source... Go to PubMed...
    16. Strub, V., Campbell, K.P. (1997): Muscular dystrophies and the dystrophyinglycoprotein complex. Curr Opin Neurol. 10: 168-175. Go to original source... Go to PubMed...
    17. Thierfelder, L., Watkins, H. et al. (1994): Alpha. tropomyosin and cardiac troponin T muations cause familial hypertrophic cardiomyopathy: a disease of sarcomere. Cell. 77: 701-712. Go to original source... Go to PubMed...
    18. Vaughan, C.J., Casey, M. et al. (2001): Identification of a Chromosome 11q23.2-q24 Locus for Familial Aortic Aneurysm Disease, a genetically heterogeneous disorder.Circulation. 103: 2469-2475. Go to original source... Go to PubMed...
    19. Watkins, H., Corner, D. et al. (1995): Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11: 434-437. Go to original source... Go to PubMed...
    20. Watkins, H., Rosenzwieg, A. et al. (1992): Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326: 1108-1114. Go to original source... Go to PubMed...
    21. Williams, R. (1995): Cardiac involvement in mitochondrial diseases, and vice versa Circulation. 91: 1266-1268. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.